<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<!-- DW6 -->
<head>
<!-- Copyright 2005 Macromedia, Inc. All rights reserved. -->
<title>RB_Pathway</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<link rel="stylesheet" href="global/styles.css" type="text/css" />
<script language="JavaScript" type="text/javascript">
//--------------- LOCALIZEABLE GLOBALS ---------------
var d=new Date();
var monthname=new Array("January","February","March","April","May","June","July","August","September","October","November","December");
//Ensure correct for language. English is "January 1, 2004"
var TODAY = monthname[d.getMonth()] + " " + d.getDate() + ", " + d.getFullYear();
//---------------   END LOCALIZEABLE   ---------------
</script>
<style type="text/css">
<!--
body {
	background-color: #FFFFFF;
}
.style1 {color: #FFFFFF}
-->
</style></head>
<body>

<!//--------------------------BEGIN HEADER-----------------------------//>
<TABLE border="0" width="100%">
 <TR>
  <TD align="left"><A HREF="http://www.curie.fr"><img border="0" src="images/logo_curie.gif" alt=""></A>
  </TD>
  <TD colspan="2" align="center">
<h2 ALIGN="center"><font color="#fa7e0c"><I>Regulation of cell cycle by Retinoblastoma protein: Systems Biology approach</I></font></h2>
  </TD>
 </TR>
</TABLE>

<table border="0" cellpadding="0" cellspacing="0" width="100%">
<tbody><tr style="padding-bottom: 5px; padding-top: 10px;">
    
</tr>
<tr>
    <td colspan="2" background="global/gray-stripes.gif">
		<img src="global/gray-stripes.gif" alt="" border="0" height="10" width="1"></td>
</tr>
<tr>
    <td colspan="2" bgcolor="#fb7e0c" height="25">		
      <table border="0" cellpadding="0" cellspacing="0" width="100%">
	<tbody><tr style="text-align: center;">
		<td><a href="./index.html">Home</a></td>
		<td width="1">|</td>
		<td><a href="./main.html">Comprehensive map</a></td>
		<td width="1">|</td>		<td><a href="./modeling.html">Modeling RB-pathway</a></td>
		<td width="1">|</td>	
		<td><a href="./download.html">Download files</a></td>
		<td width="1">|</td>			
		<td><a href="./publications.html">Publications</a></td>
		<td width="1">|</td>		
		<td><a href="./contact.html">Contact</a></td>
		<td width="1">|</td>			
		<td><a href="./links.html">Links</a></td></tr>	
	</tbody>
      </table>    </td>
</tr>
<tr>
    <td colspan="2"><img src="global/bg_blank.gif" alt="" border="0" height="2" width="45"></td>
</tr>


<tr><td colspan="2" class="pad">
</tbody>
</table>
<!//-----------------END HEADER----------------------------//>
<table width="100%" border="0" cellspacing="1" cellpadding="0">
  <tr>
    <td height="24" colspan="7" bgcolor="#999999"><h1 align="center" class="style5">Comprehensive Map of Molecular Interactions in RB/E2F Pathway </h1>
    </td>
  <tr>
    <td colspan="7" bgcolor="#999999"><img src="mm_spacer.gif" alt="" width="1" height="2" border="0" /></td>
  </tr>
  <tr>
    <td width="165" valign="top" bgcolor="#999999"><table width="172" border="1" cellpadding="0" cellspacing="0" id="navigation">
      <tr>
        <td width="168"><a href="main.html">Home</a></td>
        </tr>
	<tr>
        <td><a href="Introduction.html">Introduction</a></td>
        </tr>
	  <tr>
        <td><a href="Comprehensive.html">Comprehensive Map </a></td>
      </tr>
      <tr>
        <td><a href="Modules.html">Modules</a>
          </td>
      </tr>
      <tr>
        <td><a href="Structural.html">Structural Analysis Technique </a></td>
      </tr>
	  <tr>
        <td><a href="Comparison.html">Comparison with other databases </a></td>
      </tr>
      <tr>
        <td><a href="Conclusion.html">Conclusion</a>		</tr>
		<tr>
        <td><a href="links.html">Links </a>      </tr>
		<tr>
        <td><a href="RBE2F_refs.htm">References</a>         </td>
      </tr>
    </table>
       <br />
      &nbsp;<br />
      &nbsp;<br />
      &nbsp;<br />
    </td>
    <td width="50"><img src="mm_spacer.gif" alt="" width="50" height="1" border="0" /></td>
    <td width="100%" colspan="2" valign="top"><img src="mm_spacer.gif" alt="" width="305" height="1" border="0" /><br />
      <table border="0" cellspacing="0" cellpadding="0" width="803">
        <tr>
          <td width="100%" class="pageName style2"><p>Case study: bladder cancer </p>
          </td>
        </tr>
        <tr>
          <td height="10" class="bodyText"><div>
            <div>
              <p>We propose to illustrate  the use of the RB/E2F pathway diagram and its modular decomposition to a  concrete example in order to obtain insights into molecular mechanisms of  cancer progression. We analyze transcriptome and CGH (Comparative Genomics Hybridization)  data collected for 55 &nbsp;patients with  bladder cancers together with 5 normal urothelium samples (Stransky et al., 2006). </p>
              <h4>Activity of the modules </h4>
              <p>We estimate the  &lsquo;activity&rsquo; level of each module, based on the expression levels of the genes in the modules. For  that, we choose to use PCA-based estimation of pathway activities.  Inside every module, we determine &ldquo;hot spot genes&rdquo;, which correspond to genes  whose expression contributes mostly to the value of the module activity (details in manuscript in preparation). </p>
              <h4>Analysis of the samples </h4>
              <p>The tumour samples are divided in two  groups, non-invasive (less profound, superficial tumours) and invasive (more  profound, invading the underlying muscle) stages of the disease. The  results are consistent with our understanding of the molecular mechanism of  bladder cancer progression (Figure below). </p>
              <p>From the figure, we deduce that cyclin/CDKs complexes  play an active role in invasive cancers as well as the activation of E2F1-3 targets.. </p>
              <p>The figure also shows a particular behaviour of Cyclin D1  module which is in average less activated in invasive cancers than in  non-invasive, in agreement with the literature (Tut et al., 2001). Overexpression  of Cyclin D1 associated with amplification occurs in invasive tumours but is a  rare event (3 out of 30 tumours in this series). <br />
                  <br />
                Remarkably, all but one inhibitory  modules (RB, E2F4-5, E2F6-8, p27KIP1/p21CIP1, Wee1, APC and Apoptosis entry) were  downregulated in invasive tumours compared to superficial tumours. These  results were known for some genes (RB, P27) and point out new genes likely to be  involved in bladder tumour progression. Downregulation of &nbsp;E2F4-5 and E2F6-8 modules is consistent with  observed upregulation of their target gene modules. The upregulation of the inhibitory  p15/p16 module in invasive tumours is coherent with the increase of the E2F  modules as the p16 gene is activated by E2F1. <br />
  <br />
  <img src="activity_modules.png" alt="activity" width="735" height="727" /></p>
              <h4>Classification of the samples </h4>
              <p> It can be shown that in the  24-dimensional space of the module activities, tumour samples form two  distinctive clusters separated along the first principal component (Figure  below). </p>
              <p>This separation is completely consistent with the known two  progression pathways which exist in bladder cancer: </p>
              <p>1. The <em>Ta</em> low grade pathway and the carcinoma <em>in situ</em> invasive tumour pathway, a hallmark of the Ta pathway  being FGFR3 mutations (Billerey et al., 2001). All the low grade papillary  tumours are in the same cluster. Interestingly most of the invasive tumours  which belong to this cluster (4/5) carry FGFR3 mutations and therefore belong  to the same progression pathway. </p>
              <p>2. The other cluster, contains either only  invasive tumours or high grade (G3) superficial tumors. Furthermore the majority  of the tumours of this cluster did not carry FGFR3 mutations (29/31, compared  to 3/24 in the other group).  <br />
                  <br />
                  We also labelled some of  the samples according to the most significant genomic alterations in the  regions of genes known to be involved in cancer and participating in RB/E2F  pathway. Thus, one can notice a higher frequency of genomic alterations in the  aggressive tumours, and an amplification of E2F3 transcription factor that  drives module activities towards the extremity of the right more aggressive  cluster where there is the &lsquo;most compromised&rsquo; RB/E2F-pathway behaviour.<br />
                  <br />
                  Taken together, all these  observations give a highly consistent picture of the alterations of the RB/E2F pathway  in bladder cancer which are clearly different in the two pathways of bladder  tumour progression.</p>
              <p>We are preparing a more thorough study. </p>
              <p><img src="PC.png" alt="pc" width="666" height="440" /></p>
              </div>
          </div>          </td>
        </tr>
      </table>
      </td>
  </tr>
</table>

<!-- <div id="footer"> -->
<table border="0" cellpadding="0" cellspacing="0" width="100%">
  <tbody><tr style="padding-bottom: 5px; padding-top: 10px;">
    
    </tr>
    <tr>
      </td>
    </tr>
    <tr>
      <td colspan="2" bgcolor="#fa7e0c" height="25">
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
	  <tbody><tr style="text-align: center;">
	      <td>&nbsp;</td>
	      <td width="1">|</td>
	      <td><b>Bioinformatics Home Page: <A target="blank" href="http://bioinfo-out.curie.fr">http://bioinfo.curie.fr</A></b></td>
	      <td width="1">|</td>
	      <td><b>Institut Curie Home Page: <A target="blank" href="http://www.curie.fr">http://www.curie.fr</A></b></td>
	    </tr>
	  </tbody>
	</table>
      </td>
    </tr>
  </tbody>
</table>
<!-- </div> --></body>
</html>

